MBL2 and rheumatoid arthritis: Studies have shown that higher levels of COMP-complement C3b complexes can be detected in serum as well as synovial fluid of RA patients, suggesting that COMP can activate the human complement system via the bypass pathway and bind C1q and mannan-binding lectin (MBL), thus inhibiting the classical and lectin pathways of complement activation.